Biao He

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer
    Min Li Mo
    School of Life Sciences, Tsinghua University, Beijing 10084, China
    J Exp Clin Cancer Res 32:29. 2013
  2. pmc SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma
    Yi Zhang
    Department of Surgery, University of California, San Francisco, CA, USA
    J Exp Clin Cancer Res 32:7. 2013
  3. doi request reprint The role of stem cells in airway repair: implications for the origins of lung cancer
    Michael S Mulvihill
    Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA
    Chin J Cancer 32:71-4. 2013
  4. doi request reprint Molecular markers as therapeutic targets in lung cancer
    Hsin Hui Tseng
    Thoracic Oncology Program Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA
    Chin J Cancer 32:59-62. 2013
  5. pmc Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients
    Junichi Okamoto
    Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, California Department of Surgery, Division of Thoracic Surgery, Nippon Medical School, Tokyo, Japan
    Clin Lung Cancer 12:237-44. 2011
  6. pmc A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
    Johannes R Kratz
    University of California, San Francisco, CA 94143 1724, USA
    Lancet 379:823-32. 2012
  7. pmc Gli as a novel therapeutic target in malignant pleural mesothelioma
    Hui Li
    Thoracic Oncology Program, Department of Surgery, University of California San Francisco, San Francisco, CA, USA
    PLoS ONE 8:e57346. 2013

Collaborators

Detail Information

Publications7

  1. pmc Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer
    Min Li Mo
    School of Life Sciences, Tsinghua University, Beijing 10084, China
    J Exp Clin Cancer Res 32:29. 2013
    ..E2A-PBX1 fusion gene caused by t(1;19)(q23;p13), has been well characterized in acute lymphoid leukemia (ALL). There is no report on E2A-PBX1 fusion transcripts in non-small-cell lung cancer (NSCLC)...
  2. pmc SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma
    Yi Zhang
    Department of Surgery, University of California, San Francisco, CA, USA
    J Exp Clin Cancer Res 32:7. 2013
    ..Despite current combined regimen, its prognosis remains dismal, calling for more effective targeted therapies. We investigated whether aberrant Hh activation may play a role in mesothelioma...
  3. doi request reprint The role of stem cells in airway repair: implications for the origins of lung cancer
    Michael S Mulvihill
    Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA
    Chin J Cancer 32:71-4. 2013
    ..The implications of a stem cell origin of lung cancer are reviewed, and the importance of ongoing research to identify novel therapeutic and prognostic targets is reiterated...
  4. doi request reprint Molecular markers as therapeutic targets in lung cancer
    Hsin Hui Tseng
    Thoracic Oncology Program Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA
    Chin J Cancer 32:59-62. 2013
    ..Our understanding of the physiologic processes of tumor development provide a means to design more effective and specific drugs with less toxicity, thereby accelerating the delivery of new drug therapies to the patient's bedside...
  5. pmc Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients
    Junichi Okamoto
    Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, California Department of Surgery, Division of Thoracic Surgery, Nippon Medical School, Tokyo, Japan
    Clin Lung Cancer 12:237-44. 2011
    ..This study assessed the significance of EMX2 as a prognostic biomarker in lung adenocarcinoma including bronchioloalveolar carcinoma (BAC)...
  6. pmc A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
    Johannes R Kratz
    University of California, San Francisco, CA 94143 1724, USA
    Lancet 379:823-32. 2012
    ..We aimed to develop and validate a practical, reliable assay that improves risk stratification compared with conventional staging...
  7. pmc Gli as a novel therapeutic target in malignant pleural mesothelioma
    Hui Li
    Thoracic Oncology Program, Department of Surgery, University of California San Francisco, San Francisco, CA, USA
    PLoS ONE 8:e57346. 2013
    ..In summary, Gli activation plays a critical role in MPM. Inhibition of Gli function holds strong potential to become a novel, clinically effective approach to treat MPM...

Research Grants2

  1. Small molecule inhibitors of Wnt-2 transcription in NSCLC
    Biao He; Fiscal Year: 2009
    ..The heart of our proposal is translationally focused, specifically the development of novel and innovative small molecule inhibitors of the Wnt transcription as molecular-targeted therapies against lung cancer. ..
  2. Small molecule inhibitors of Wnt-2 transcription in NSCLC
    Biao He; Fiscal Year: 2010
    ..The heart of our proposal is translationally focused, specifically the development of novel and innovative small molecule inhibitors of the Wnt transcription as molecular-targeted therapies against lung cancer. ..